{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T06:45:50Z","timestamp":1788417950768,"version":"build-2803163510"},"reference-count":30,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2021,8,3]],"date-time":"2021-08-03T00:00:00Z","timestamp":1627948800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["1 K01 AA027811-01"],"award-info":[{"award-number":["1 K01 AA027811-01"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,4,11]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>Most women may have temporary pain for which they use analgesics, but those with autoimmune disorders have chronic pain that may be exacerbated for some during pregnancy. This study aimed to determine whether prenatal acetaminophen use was associated with an increased risk of adverse pregnancy and birth outcomes in women with autoimmune disorders.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Participants were enrolled between 2004 and 2018 in the MotherToBaby cohort study and limited to women with an autoimmune disorder (n\u2009=\u20091821). Self-reported acetaminophen use was characterized over gestation for indication, timing of use and duration. Cumulative acetaminophen use through 20 and 32\u2009weeks was categorized into quintiles, with no acetaminophen use as the reference category. The association between acetaminophen quintile and preeclampsia or pregnancy-induced hypertension, small for gestational age and preterm birth was examined using adjusted multiple log-linear regression.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Overall, 74% of women reported acetaminophen use during pregnancy. The most often reported indication for using acetaminophen was headache\/migraines, followed by pain and injury. Risk of preeclampsia was 1.62 (95% CI: 1.10, 2.40) times greater for those in the fifth quintile of cumulative acetaminophen use through 20\u2009weeks compared with those with no acetaminophen use. There were no associations with lower use quintiles, nor for the other outcomes.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>The highest quintile of cumulative acetaminophen was associated with a modestly increased risk for preeclampsia. Some women with autoimmune conditions have pain throughout pregnancy; clinicians and patients should discuss approaches to best avoid high levels of acetaminophen in their pain management strategies.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/rheumatology\/keab623","type":"journal-article","created":{"date-parts":[[2021,7,30]],"date-time":"2021-07-30T11:12:58Z","timestamp":1627643578000},"page":"1630-1638","source":"Crossref","is-referenced-by-count":10,"title":["Prenatal acetaminophen use in women with autoimmune disorders and adverse pregnancy and birth outcomes"],"prefix":"10.1093","volume":"61","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3155-1107","authenticated-orcid":false,"given":"Jordan A","family":"Killion","sequence":"first","affiliation":[{"name":"Division of Epidemiology, Herbert Wertheim School of Public Health and Human Longevity Science, University of California, San Diego, La Jolla"},{"name":"Department of Epidemiology, School of Public Health, San Diego State University, San Diego"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Chambers","sequence":"additional","affiliation":[{"name":"Division of Epidemiology, Herbert Wertheim School of Public Health and Human Longevity Science, University of California, San Diego, La Jolla"},{"name":"Department of Pediatrics, University of California, San Diego, La Jolla"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chelsey J F","family":"Smith","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Allergy, and Immunology, University of California, San Diego, La Jolla, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gretchen","family":"Bandoli","sequence":"additional","affiliation":[{"name":"Division of Epidemiology, Herbert Wertheim School of Public Health and Human Longevity Science, University of California, San Diego, La Jolla"},{"name":"Department of Pediatrics, University of California, San Diego, La Jolla"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2021,8,3]]},"reference":[{"key":"2022041112512106900_keab623-B1","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1001\/jamapediatrics.2016.1775","article-title":"Association of acetaminophen use during pregnancy with behavioral problems in childhood: evidence against confounding","volume":"170","author":"Stergiakouli","year":"2016","journal-title":"JAMA Pediatr"},{"key":"2022041112512106900_keab623-B2","first-page":"1987","article-title":"Acetaminophen use in pregnancy and neurodevelopment: attention function and autism spectrum symptoms","volume":"45","author":"Avella-Garcia","year":"2016","journal-title":"Int J Epidemiol"},{"key":"2022041112512106900_keab623-B3","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1093\/ije\/dyt183","article-title":"Prenatal paracetamol exposure and child neurodevelopment: a sibling-controlled cohort study","volume":"42","author":"Brandlistuen","year":"2013","journal-title":"Int J Epidemiol"},{"key":"2022041112512106900_keab623-B4","doi-asserted-by":"crossref","first-page":"e108210","DOI":"10.1371\/journal.pone.0108210","article-title":"Associations between acetaminophen use during pregnancy and ADHD symptoms measured at ages 7 and 11 years","volume":"9","author":"Thompson","year":"2014","journal-title":"PLoS One"},{"key":"2022041112512106900_keab623-B5","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1001\/jamapediatrics.2013.4914","article-title":"Acetaminophen use during pregnancy, behavioral problems, and hyperkinetic disorders","volume":"168","author":"Liew","year":"2014","journal-title":"JAMA Pediatr"},{"key":"2022041112512106900_keab623-B6","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.ajog.2005.02.100","article-title":"Use of over-the-counter medications during pregnancy","volume":"193","author":"Werler","year":"2005","journal-title":"Am J Obstet Gynecol"},{"key":"2022041112512106900_keab623-B7","first-page":"548","article-title":"Over-the-counter medications in pregnancy","volume":"90","author":"Servey","year":"2014","journal-title":"Am Fam Physician"},{"key":"2022041112512106900_keab623-B8","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1093\/ije\/dyp151","article-title":"Use of acetaminophen during pregnancy and risk of adverse pregnancy outcomes","volume":"38","author":"Rebordosa","year":"2009","journal-title":"Int J Epidemiol"},{"key":"2022041112512106900_keab623-B9","doi-asserted-by":"crossref","first-page":"371","DOI":"10.3109\/14767050903334877","article-title":"Use of acetaminophen during pregnancy and risk of preeclampsia, hypertensive and vascular disorders: a birth cohort study","volume":"23","author":"Rebordosa","year":"2010","journal-title":"J Matern Fetal Neonatal Med"},{"key":"2022041112512106900_keab623-B10","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1111\/ppe.12595","article-title":"Acetaminophen use in pregnancy: examining prevalence, timing and indication of use in a prospective birth cohort","volume":"34","author":"Bandoli","year":"2020","journal-title":"Paediatr Perinat Epidemiol"},{"key":"2022041112512106900_keab623-B11","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.coph.2013.03.004","article-title":"How safe are anti-rheumatic drugs during pregnancy?","volume":"13","author":"\u00d8stensen","year":"2013","journal-title":"Curr Opin Pharmacol"},{"key":"2022041112512106900_keab623-B12","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.autrev.2005.03.001","article-title":"Pregnancy and autoimmunity: maternal treatment and maternal disease influence on pregnancy outcome","volume":"4","author":"Tincani","year":"2005","journal-title":"Autoimmun Rev"},{"key":"2022041112512106900_keab623-B13","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1097\/BOR.0000000000000054","article-title":"Non-steroidal anti inflammatory drugs, glucocorticoids and disease modifying anti-rheumatic drugs for the management of rheumatoid arthritis before and during pregnancy","volume":"26","author":"Bermas","year":"2014","journal-title":"Curr Opin Rheumatol"},{"key":"2022041112512106900_keab623-B14","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1136\/ard.2008.105262","article-title":"Increased risk of adverse pregnancy outcomes in women with rheumatoid arthritis: a nationwide population-based study","volume":"69","author":"Lin","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"2022041112512106900_keab623-B15","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/s10995-006-0073-3","article-title":"Pregnancy outcomes in women with rheumatoid arthritis in Washington State","volume":"10","author":"Reed","year":"2006","journal-title":"Matern Child Health J"},{"key":"2022041112512106900_keab623-B16","doi-asserted-by":"crossref","first-page":"2750","DOI":"10.1007\/s10620-015-3677-x","article-title":"Inflammatory bowel disease increases risk of adverse pregnancy outcomes: a meta-analysis","volume":"60","author":"O'Toole","year":"2015","journal-title":"Dig Dis Sci"},{"key":"2022041112512106900_keab623-B17","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1053\/j.gastro.2007.07.019","article-title":"Pregnancy outcomes in women with inflammatory bowel disease: a large community-based study from Northern California","volume":"133","author":"Mahadevan","year":"2007","journal-title":"Gastroenterology"},{"key":"2022041112512106900_keab623-B18","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1007\/s00296-016-3525-0","article-title":"Pregnancy outcomes in women with childhood-onset and adult-onset systemic lupus erythematosus: a comparative study","volume":"36","author":"Saavedra","year":"2016","journal-title":"Rheumatol Int"},{"key":"2022041112512106900_keab623-B19","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.jaut.2016.07.010","article-title":"Fetal outcome and recommendations of pregnancies in lupus nephritis in the 21st century. A prospective multicenter study","volume":"74","author":"Moroni","year":"2016","journal-title":"J Autoimmun"},{"key":"2022041112512106900_keab623-B20","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.joen.2015.01.024","article-title":"Acetaminophen: old drug, new issues","volume":"41","author":"Aminoshariae","year":"2015","journal-title":"J Endod"},{"key":"2022041112512106900_keab623-B21","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1111\/j.1365-2710.2012.01371.x","article-title":"Effectiveness of FDA's new over-the-counter acetaminophen warning label in improving consumer risk perception of liver damage","volume":"37","author":"Goyal","year":"2012","journal-title":"J Clin Pharm Ther"},{"key":"2022041112512106900_keab623-B22","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1002\/art.24003","article-title":"Disease activity of rheumatoid arthritis during pregnancy: results from a nationwide prospective study","volume":"59","author":"de Man","year":"2008","journal-title":"Arthritis Rheum"},{"key":"2022041112512106900_keab623-B23","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.3390\/jcm9061890","article-title":"Prevalence of migraine and neuropathic pain in rheumatic diseases","volume":"9","author":"Mathieu","year":"2020","journal-title":"J Clin Med"},{"key":"2022041112512106900_keab623-B24","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1080\/14767050802379056","article-title":"Is it time to re-evaluate our use of acetaminophen in certain sub-groups of pregnant women?","volume":"21","author":"Zelop","year":"2008","journal-title":"J Matern Fetal Neonatal Med"},{"key":"2022041112512106900_keab623-B25","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1096\/fj.06-8015com","article-title":"Acetaminophen inhibits prostanoid synthesis by scavenging the PGHS-activator peroxynitrite","volume":"22","author":"Schildknecht","year":"2008","journal-title":"FASEB J"},{"key":"2022041112512106900_keab623-B26","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.clpt.2005.09.009","article-title":"New insights into the mechanism of action of acetaminophen: its clinical pharmacologic characteristics reflect its inhibition of the two prostaglandin H2 synthases","volume":"79","author":"Aronoff","year":"2006","journal-title":"Clin Pharmacol Ther"},{"key":"2022041112512106900_keab623-B27","first-page":"412","article-title":"Tumor necrosis factor-alpha, interleukin-6, and interleukin-10 levels are altered in preeclampsia: a systematic review and meta-analysis","volume":"70","author":"Lau","year":"2013","journal-title":"Am J Reprod Immunol"},{"key":"2022041112512106900_keab623-B28","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1111\/ppe.12415","article-title":"Agreement between maternal report and medical records during pregnancy: medications for rheumatoid arthritis and asthma","volume":"32","author":"Palmsten","year":"2018","journal-title":"Paediatr Perinat Epidemiol"},{"key":"2022041112512106900_keab623-B29","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1002\/acr.24037","article-title":"Mediation of adverse pregnancy outcomes in autoimmune conditions by pregnancy complications: a mediation analysis of autoimmune conditions and adverse pregnancy outcomes","volume":"72","author":"Bandoli","year":"2020","journal-title":"Arthritis Care Res (Hoboken"},{"key":"2022041112512106900_keab623-B30","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.rdc.2017.04.013","article-title":"A review of systemic corticosteroid use in pregnancy and the risk of select pregnancy and birth outcomes","volume":"43","author":"Bandoli","year":"2017","journal-title":"Rheum Dis Clin North Am"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/rheumatology\/advance-article-pdf\/doi\/10.1093\/rheumatology\/keab623\/40432643\/keab623.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/61\/4\/1630\/43356163\/keab623.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/61\/4\/1630\/43356163\/keab623.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,11]],"date-time":"2022-04-11T12:57:34Z","timestamp":1649681854000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article\/61\/4\/1630\/6337992"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,3]]},"references-count":30,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2021,8,3]]},"published-print":{"date-parts":[[2022,4,11]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/keab623","relation":{},"ISSN":["1462-0324","1462-0332"],"issn-type":[{"value":"1462-0324","type":"print"},{"value":"1462-0332","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,4,1]]},"published":{"date-parts":[[2021,8,3]]}}}